Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Ecopetrol
EC
4
Taylor Morrison Home
TMHC
5
KB Home
KBH
US Stock MarketDetailed Quotes
OKUR OnKure Therapeutics
- 4.460
- -0.230-4.90%
Close Mar 28 16:00 ET
- 4.460
- 0.0000.00%
Post 16:00 ET
59.92MMarket Cap-1.13P/E (TTM)
4.581High4.430Low5.75KVolume4.575Open4.690Pre Close25.81KTurnover0.14%Turnover RatioLossP/E (Static)13.44MShares19.99952wk High0.58P/B18.66MFloat Cap4.43052wk Low--Dividend TTM4.18MShs Float171.799Historical High--Div YieldTTM3.23%Amplitude4.430Historical Low4.493Avg Price1Lot Size
OnKure Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 47.25%54.39M | 260.07%33.8M | -77.67%4.66M | 66.12%14.34M | 12.33%9.83M | 24.08%36.93M | -21.11M | 20.89M | 8.63M | 8.75M |
| Selling and administrative expenses | 119.78%10.59M | 74.93%-3.56M | -48.25%3.76M | 220.63%3.59M | 2.93%1.27M | 23.44%4.82M | ---14.22M | --7.27M | --1.12M | --1.23M |
| -General and administrative expense | 119.78%10.59M | 74.93%-3.56M | -48.25%3.76M | 220.63%3.59M | 2.93%1.27M | 23.44%4.82M | ---14.22M | --7.27M | --1.12M | --1.23M |
| Research and development costs | 36.37%43.8M | 641.91%37.36M | -93.36%904K | 43.09%10.75M | 13.86%8.57M | 24.18%32.12M | ---6.89M | --13.62M | --7.51M | --7.52M |
| Operating profit | -47.25%-54.39M | -260.07%-33.8M | 77.67%-4.66M | -66.12%-14.34M | -12.33%-9.83M | -24.08%-36.93M | 21.11M | -20.89M | -8.63M | -8.75M |
| Net non-operating interest income expense | 5.55%1.71M | -54.77%204K | 304.11%295K | 538.98%1.62M | 451K | 73K | ||||
| Non-operating interest income | 24.03%2.01M | ---- | ---- | -49.00%230K | 304.11%295K | 538.98%1.62M | ---- | ---- | --451K | --73K |
| Non-operating interest expense | --300K | ---- | ---- | --26K | ---- | --0 | ---- | ---- | --0 | ---- |
| Other net income (expense) | -42.55%972K | 1.69M | ||||||||
| Other non- operating income (expenses) | ---- | ---- | -42.55%972K | ---- | ---- | ---- | ---- | --1.69M | ---- | ---- |
| Income before tax | -49.17%-52.67M | -290.00%-35.19M | 80.77%-3.69M | -72.79%-14.14M | -9.87%-9.54M | -19.65%-35.31M | 18.52M | -19.2M | -8.18M | -8.68M |
| Income tax | ||||||||||
| Net income | -49.17%-52.67M | -290.00%-35.19M | 80.77%-3.69M | -72.79%-14.14M | -9.87%-9.54M | -19.65%-35.31M | 18.52M | -19.2M | -8.18M | -8.68M |
| Net income continuous Operations | -49.17%-52.67M | -290.00%-35.19M | 80.77%-3.69M | -72.79%-14.14M | -9.87%-9.54M | -19.65%-35.31M | --18.52M | ---19.2M | ---8.18M | ---8.68M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -49.17%-52.67M | -290.00%-35.19M | 80.77%-3.69M | -72.79%-14.14M | -9.87%-9.54M | -19.65%-35.31M | 18.52M | -19.2M | -8.18M | -8.68M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -49.17%-52.67M | -290.00%-35.19M | 80.77%-3.69M | -72.79%-14.14M | -9.87%-9.54M | -19.65%-35.31M | 18.52M | -19.2M | -8.18M | -8.68M |
| Basic earnings per share | -477.23%-15.28 | -198.66%-1.37 | 80.77%-0.2768 | -72.79%-1.0599 | -9.87%-0.7149 | -19.65%-2.6471 | 1.3886 | -1.439 | -0.6134 | -0.6506 |
| Diluted earnings per share | -477.23%-15.28 | -198.66%-1.37 | 80.77%-0.2768 | -72.79%-1.0599 | -9.87%-0.7149 | -19.65%-2.6471 | 1.3886 | -1.439 | -0.6134 | -0.6506 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings